Initial combination of metformin, sitagliptin, and empagliflozin in drug‐naïve patients with type 2 diabetes: Safety and metabolic effects. Issue 4 (2nd January 2022) - Lim, Soo; Sohn, Minji; Shin, Yujin; Ferrannini, Ele